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Enlargement of choroid plexus in 
complex regional pain syndrome
Guangyu Zhou1, Jaakko Hotta1,2,3, Maria K. Lehtinen4, Nina Forss1,3 & Riitta Hari1
The choroid plexus, located in brain ventricles, has received surprisingly little attention in clinical 
neuroscience. In morphometric brain analysis, we serendipitously found a 21% increase in choroid 
plexus volume in 12 patients suffering from complex regional pain syndrome (CRPS) compared with 
age- and gender-matched healthy subjects. No enlargement was observed in a group of 8 patients 
suffering from chronic pain of other etiologies. Our findings suggest involvement of the choroid 
plexus in the pathogenesis of CRPS. Since the choroid plexus can mediate interaction between 
peripheral and brain inflammation, our findings pinpoint the choroid plexus as an important target 
for future research of central pain mechanisms.
The choroid plexus is the key producer of cerebrospinal fluid, which provides a fluid cushion for the 
central nervous system and a sink for nervous-system biomarkers and debris1,2. The choroid plexus also 
secretes into the cerebrospinal fluid a wide array of proteins and other signaling substances that instruct 
the development and maintenance of the mammalian brain2. Moreover, the choroid plexus provides a 
point of entry for immune cells into the brain, thereby linking the peripheral and central inflammatory 
systems3,4.
Until now, the choroid plexus has been largely neglected in clinical neuroscience and its potential 
role in neurological disorders has remained unresolved5. For example in human brain imaging studies, 
choroid plexus volume is typically not discussed or quantified with a few exceptions6–9. The normal-size 
criteria for the pediatric population were only recently proposed10, and similar criteria for the adult 
choroid plexus remain to be established.
Here, we report an unexpected association between choroid plexus volume and central pain. Using 
MRI, we found choroid plexus enlargement in patients suffering from complex regional pain syndrome 
(CRPS), a chronic and multifactorial pain disorder that initially follows a minor peripheral trauma and 
subsequently spreads to areas beyond the original lesion area11,12. The mechanisms underlying the CRPS 
evolvement are still poorly understood, and thus our findings implicating the involvement of choroid 
plexus in CRPS could elucidate the pathogenesis of this debilitating condition.
Results
We performed MRI image analysis of 29 distinct subcortical brain regions in CRPS patients and healthy 
control subjects to identify if changes in these regions correlated with CRPS. Image analysis from a cohort 
of 12 CRPS type 1 female patients revealed a striking increase in the volume of the right lateral-ventricle 
choroid plexus. Figure 1 shows group-wise volumes of the right lateral-ventricle choroid plexus, with a 
statistically significant group effect (F(2, 29) = 8.31, effect size η 2 = 0.36, FDR-adjusted p = 0.041). The 
right lateral-ventricle choroid plexus was 21.1% larger in the CRPS patients compared with the healthy 
control subjects (effect size Cohen’s d = 1.53, corrected p = 0.0073), and 12.6% larger than in the other 
control group consisting of patients suffering from chronic pain of other etiologies (d = 1.35, corrected 
p = 0.045). We also found a large group effect on the volumes of the left lateral ventricle (F(2,29) = 6.84, 
η 2 = 0.32, uncorrected p = 0.0037, FDR-adjusted p = 0.054) and the right thalamus (F(2,29) = 5.46, 
1Department of Neuroscience and Biomedical Engineering, Aalto University, FI-00076 AALTO, Espoo 02150, 
Finland. 2Aalto NeuroImaging, Aalto University, Espoo 02150, Finland. 3Clinical Neurosciences, Neurology, 
University of Helsinki and Helsinki University Hospital, Helsinki 00290, Finland. 4Department of Pathology, Boston 
Children’s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. Correspondence and requests for 
materials should be addressed to G.Z. (email: guangyu.zhou@aalto.fi)
received: 13 May 2015
Accepted: 20 August 2015
Published: 21 September 2015
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 5:14329 | DOi: 10.1038/srep14329
η 2 = 0.27, uncorrected p = 0.0097, FDR-adjusted p = 0.094). Patients with CRPS had a larger left lat-
eral ventricle (d = 1.48, corrected p = 0.011) and smaller right thalamus (d = 1.23, corrected p = 0.024) 
than the healthy control subjects. No statistically significant group effects were observed for any of the 
other structures examined (all uncorrected p > 0.05, Table 1). No statistically significant correlation was 
observed between CRPS duration and the volume of the right lateral-ventricle choroid plexus, left lateral 
ventricle, or right thalamus (all p > 0.5).
Discussion
We report an unexpected enlargement of the choroid plexus in CRPS patients compared with age- and 
gender-matched healthy control subjects. While the choroid plexus did not belong to our initial list of 
structures anticipated to be involved in CRPS, the observed volume increase of 21.1% raises the possi-
bility that the choroid plexus plays a role in the pathogenesis of CRPS.
Previous studies have reported gray-matter changes in CRPS but have not examined the choroid 
plexus13–16. These studies used voxel-based morphometry analysis of brain structures, and although they 
addressed subcortical structures as well, they failed to detect abnormalities in e.g. thalamus14–16. A key 
difference between our study and previous reports is the analysis method. We analyzed group differences 
in brain structures at volume rather than voxel level, and these approaches can yield distinct results17. 
Our approach also uncovered a previously unknown change in ventricular volume in CRPS patients, 
which again may have been facilitated by our approach to analyze hemisphere-specific structural changes 
rather than combining total ventricular volume.
While our study identified increased volumes of the CRPS patients’ right lateral-ventricle choroid 
plexus, right thalamus, and left lateral ventricle, the mechanisms underlying these structural changes 
remain unknown. The increased volume of the choroid plexus, for example, could result from the con-
current activation of several biological processes including increased proliferation of choroid-plexus cells 
(as has been shown in cases of direct tissue injury18), invasion of the choroid plexus by non-resident 
immune cells, and/or edema. Future studies will be required to elucidate the precise physiological pro-
cesses and mechanisms regulating structural changes in CRPS.
Growing evidence suggests a role for the choroid plexus in the pathophysiology of pain. For example, 
the choroid plexus is an important mediator between brain and peripheral inflammation (for a review, 
see ref. 3), and recent findings suggest an association between brain inflammation and chronic pain19. 
Analyses of blood and cerebrospinal fluid samples from CRPS patients have revealed increased levels of 
cytokines20. Together with our observations that the choroid plexus is enlarged in CRPS, these findings 
support contribution of central and peripheral inflammation to the pathophysiology of CRPS.
Another association between choroid plexus and pain stems from Aquaporin 1 (AQP-1), a hydrophobic 
water-transporting protein expressed at the plasma membrane of choroid plexus epithelial cells21. AQP-1 
Figure 1. Volumes and 3D rendering of the right lateral-ventricle choroid plexus. The scatter plot shows 
volumes of the right lateral-ventricle choroid plexus in CRPS patients (CRPS), pain patients suffering from 
chronic pain of other etiologies (PAT), and controls subjects (CON). **Bonferroni-corrected p = 0.0073 in 
two-tailed Mann-Whitney U test, *p = 0.045, n.s. p = 1.69. Red lines = mean, blue lines = standard deviation. 
The insert shows a 3D model of the right lateral-ventricle choroid plexus (shown in red) of one CRPS 
patient, which was created using FSLView’s 3D Rendering.
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tunes pain perception in mouse dorsal root ganglia22 where AQP-1 is upregulated following peripheral 
nerve injury or trauma. In the dorsal column, AQP-1 has a dual role in the transmission of noxious stim-
uli as well as in regulating axonal growth. Since AQP-1 is highly expressed by choroid plexus epithelial 
cells, these findings raise a possibility that AQP-1-targeted treatments might provide a future therapeutic 
avenue for CRPS23. Moreover, the choroid plexus secretes hundreds of factors into the cerebrospinal fluid, 
including proenkephalin24, an endogenous opioid polypeptide hormone. Choroid plexus-proenkephalin 
is highly expressed and secreted during brain development, and this process persists, albeit at lower 
intensity in adulthood. While the site(s) of action and role(s) for choroid-plexus-secreted proenkephalin 
remain to be identified, these findings suggest that the choroid plexus may be involved in mediating 
responses to pain.
In summary, our results demonstrate an earlier-unexplored association between the choroid plexus 
and central pain. As limitations of our study we acknowledge the small sample size that resulted in lim-
ited statistical power, with the risk for type I errors despite the large effect size. Moreover, while all of our 
subjects suffered from right-sided pain, our data do not explain the right-hemisphere lateralization of the 
effect. However, our findings suggest that quantifying choroid plexus volume by contrast-enhanced MRI 
in future studies with larger cohorts could improve our understanding of the pathophysiology underlying 
CRPS. Finally, pairing these studies with animal models of CRPS could open avenues for developing 
improved diagnostics and therapeutic approaches for CRPS.
Region CRPS (cm3) PAT (cm3) CON (cm3) F(2,29) P value η2
FDR 
adjusted
Choroid Plexus R 2.01 ± 0.18 1.78 ± 0.15 1.66 ± 0.27 8.31 0.0014 0.364 0.041
L 1.68 ± 0.29 1.60 ± 0.10 1.51 ± 0.24 1.58 0.2229 0.098 0.714
Lateral Ventricle R 9.30 ± 3.24 7.94 ± 2.67 7.25 ± 2.87 1.47 0.2467 0.092 0.714
L 10.89 ± 3.05 8.58 ± 2.60 6.78 ± 2.45 6.84 0.0037 0.320 0.054
Inferior Lateral Ventricle R 0.35 ± 0.13 0.34 ± 0.13 0.31 ± 0.14 0.30 0.7459 0.020 0.901
L 0.48 ± 0.14 0.41 ± 0.26 0.37 ± 0.11 1.22 0.3111 0.077 0.714
Third Ventricle 1.10 ± 0.22 0.97 ± 0.43 0.96 ± 0.20 0.88 0.4249 0.057 0.817
Fourth Ventricle 1.55 ± 0.29 1.49 ± 0.25 1.54 ± 0.32 0.11 0.8946 0.008 0.977
Thalamus R 6.10 ± 0.43 6.27 ± 0.49 6.89 ± 0.80 5.46 0.0097 0.274 0.094
L 6.24 ± 0.48 6.40 ± 0.59 6.89 ± 0.93 2.64 0.0883 0.154 0.512
Hippocampus R 4.17 ± 0.29 4.17 ± 0.47 4.32 ± 0.37 0.61 0.5518 0.040 0.842
L 3.84 ± 0.29 3.87 ± 0.46 4.03 ± 0.31 1.07 0.3566 0.069 0.739
Caudate R 3.57 ± 0.32 3.58 ± 0.57 3.69 ± 0.36 0.30 0.7448 0.020 0.901
L 3.41 ± 0.32 3.48 ± 0.49 3.67 ± 0.34 1.60 0.2185 0.100 0.714
Putamen R 5.31 ± 0.58 5.38 ± 0.40 5.47 ± 0.32 0.35 0.7053 0.024 0.901
L 5.77 ± 0.53 5.85 ± 0.69 5.81 ± 0.57 0.05 0.9520 0.003 0.977
Pallidum R 1.50 ± 0.09 1.51 ± 0.24 1.56 ± 0.21 0.46 0.6372 0.031 0.880
L 1.59 ± 0.17 1.55 ± 0.27 1.67 ± 0.27 0.68 0.5144 0.045 0.829
Amygdala R 1.85 ± 0.23 1.82 ± 0.43 1.85 ± 0.26 0.03 0.9749 0.002 0.977
L 1.64 ± 0.18 1.62 ± 0.42 1.62 ± 0.20 0.02 0.9770 0.002 0.977
Accumbens Area R 0.69 ± 0.10 0.73 ± 0.13 0.71 ± 0.12 0.23 0.7953 0.016 0.923
L 0.63 ± 0.10 0.66 ± 0.12 0.68 ± 0.16 0.49 0.6197 0.032 0.880
Ventral Diencephaion R 3.81 ± 0.17 3.84 ± 0.38 3.98 ± 0.27 1.19 0.3201 0.076 0.714
L 3.97 ± 0.23 4.19 ± 0.43 4.23 ± 0.27 2.42 0.1066 0.143 0.515
Cerebellum Cortex R 47.85 ± 4.06 48.79 ± 4.48 49.79 ± 2.72 0.82 0.4510 0.053 0.817
L 48.55 ± 3.97 49.29 ± 3.90 50.30 ± 3.21 0.68 0.5133 0.045 0.829
Cerebellum White Matter R 14.33 ± 1.22 14.86 ± 2.14 15.42 ± 1.38 1.51 0.2373 0.094 0.714
L 14.27 ± 1.12 14.82 ± 1.37 15.59 ± 1.38 3.17 0.0567 0.180 0.411
Brainstem 19.32 ± 1.11 19.64 ± 1.52 20.41 ± 2.34 1.19 0.3188 0.076 0.714
Table 1.  Volumetric analysis of variance results for all 29 Freesurfer derived subcortical structures. 
Volume data are shown as mean ± SD and were adjusted for confounding factors including gender, age, 
scanner, and total intracranial volume using linear regression method. CRPS, patients with complex regional 
pain syndrome; PAT, patients suffering from chronic pain of other etiologies; CON, control subjects; FDR, 
false discovery rate; R, right hemisphere; L, left hemisphere.
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Methods
This study was approved by the ethics committee of the Helsinki and Uusimaa Hospital District. Subjects 
signed informed consent before participation, and all methods were carried out in accordance with the 
approved guidelines.
Subjects. We analyzed the structural MRIs of 32 right-handed subjects: (1) twelve CRPS type 1 
patients (all females, ages 36–58 years, mean 46; all with right-sided pain; mean disease duration ± SD: 
5.8 ± 4.5 years, range 1.4–15.5 years), (2) eight chronic pain patients of other etiologies (2 females, 
6 males; ages 38–72 years, mean 54; mean disease duration: 8.5 ± 10.1 years, range 1–30 years), and (3) 
twelve healthy control subjects (all females, ages 25–60 years, mean 45).
During subject recruitment, CRPS diagnosis was confirmed by clinical examination performed by an 
experienced neurologist at the Pain Clinic of the Helsinki University Hospital. Eleven patients fulfilled 
the “research criteria” for CRPS, and the remaining patient fulfilled the less stringent “clinical criteria” 
for CRPS25. None of the patients showed electroneuromyographic signs of major nerve injury, thereby 
agreeing with the diagnosis of CRPS type 1.
Prior to MRI measurements on the test day, CRPS patients reported a pre-MRI mean pain intensity 
of 5.5 ± 1.6 (range 3–7) on scale from 0 (no pain) to 10 (maximum pain), and the patients of the control 
group reported a mean pain intensity of 5.8 ± 1.8 (range 3–8). Neither disease duration nor pain inten-
sity were found to differ between the two patient groups (p = 0.97 and p = 0.88, respectively, two-tailed 
Mann-Whitney U test).
Brain MRI. We acquired high-resolution 1 × 1 × 1 mm3 T1-weighted MR images at the Advanced 
Magnetic Imaging Centre of Aalto NeuroImaging, Aalto University. Nine CRPS patients, eight control 
pain patients, and nine healthy control subjects were scanned with a Signa 3T scanner (model EXCITE 
for the control pain patients and HDxt for the others; GE Healthcare, Milwaukee, Wisconsin) with a 
16-channel head coil. Four CRPS patients and four control subjects were scanned with a Magnetom 
Skyra 3T scanner (Siemens Healthcare, Erlangen, Germany) with a 30-channel head coil.
Images were acquired with ultrafast gradient-echo 3D sequences (3D fast SPGR with GE scan-
ner, MPRAGE with Siemens scanner) with 176 sagittal slices and a matrix size of 256 × 256. For the 
CRPS patients and healthy control subjects, the other imaging parameters were TR 10 ms/2530 ms, TE 
2.9 ms/3.3 ms, flip angle 15°/7° for GE/Siemens scanner. For the control pain patients (GE scanner) the 
corresponding parameters were TR 9 ms, TE 1.9 ms, FA 15°.
Image Analysis. Volumetric segmentation of the MRI images was performed in a standard man-
ner using Freesurfer image analysis suite (http://surfer.nmr.mgh.harvard.edu). The processing included 
motion correction, removal of non-brain tissue using a hybrid watershed/surface deformation proce-
dure26, automated Talairach transformation, and segmentation of the subcortical white matter and deep 
gray matter volumetric structures27,28. We analyzed the volumes of 29 subcortical structures (Table 1).
Statistical Analysis. The MRI data were first adjusted for confounding factors including gender, age, 
scanner, and total intracranial volume using linear regression method. We conducted a one-way anal-
ysis of variance to compare the group effect on the 29 volumes. Multiple comparisons were corrected 
using the false discovery rate (FDR) controlling procedure29. Post-hoc analysis was performed with three 
pair-wise, independent, two-tailed Mann-Whitney U tests, followed by Bonferroni correction.
We calculated the Pearson correlation (covariates: age, scanner, and total intracranial volume) between 
disease duration and all brain volumes where our previous analysis had indicated a statistically significant 
group effect in the CRPS cohort.
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